BlackRock’s Mesoblast MESO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.99M | Buy |
664,280
+33,425
| +5% | +$497K | ﹤0.01% | 3724 |
|
|
2026
Q1 | $9.7M | Sell |
630,855
-45,510
| -7% | -$758K | ﹤0.01% | 3533 |
|
|
2025
Q4 | $12.2M | Buy |
676,365
+135,948
| +25% | +$2.34M | ﹤0.01% | 3372 |
|
|
2025
Q3 | $8.71M | Sell |
540,417
-116,417
| -18% | -$1.7M | ﹤0.01% | 3524 |
|
|
2025
Q2 | $7.15M | Sell |
656,834
-58,094
| -8% | -$651K | ﹤0.01% | 3580 |
|
|
2025
Q1 | $8.92M | Sell |
714,928
-12,324
| -2% | -$203K | ﹤0.01% | 3369 |
|
|
2024
Q4 | $14.4M | Buy |
727,252
+645,773
| +793% | +$7.15M | ﹤0.01% | 3233 |
|
|
2024
Q3 | $666K | Buy |
81,479
+11,249
| +16% | +$76.4K | ﹤0.01% | 4262 |
|
|
2024
Q2 | $478K | Buy |
70,230
+59,395
| +548% | +$406K | ﹤0.01% | 4355 |
|
|
2024
Q1 | $54.3K | Buy |
10,835
+3,356
| +45% | +$7.15K | ﹤0.01% | 4854 |
|
|
2023
Q4 | $16.5K | Sell |
7,479
-14,943
| -67% | -$35.6K | ﹤0.01% | 5108 |
|
|
2023
Q3 | $55.2K | Sell |
22,422
-47,936
| -68% | -$229K | ﹤0.01% | 4984 |
|
|
2023
Q2 | $550K | Buy |
70,358
+28,626
| +69% | +$205K | ﹤0.01% | 4458 |
|
|
2023
Q1 | $275K | Buy |
41,732
+14,319
| +52% | +$94.8K | ﹤0.01% | 4696 |
|
|
2022
Q4 | $160K | Sell |
27,413
-413,529
| -94% | -$2.59M | ﹤0.01% | 4912 |
|
|
2022
Q3 | $2.25M | Buy |
440,942
+16,173
| +4% | +$97.8K | ﹤0.01% | 4131 |
|
|
2022
Q2 | $1.89M | Sell |
424,769
-7,550
| -2% | -$52K | ﹤0.01% | 4270 |
|
|
2022
Q1 | $3.65M | Buy |
432,319
+74,511
| +21% | +$634K | ﹤0.01% | 4120 |
|
|
2021
Q4 | $3.44M | Sell |
357,808
-45,927
| -11% | -$534K | ﹤0.01% | 4164 |
|
|
2021
Q3 | $4.85M | Buy |
403,735
+13,016
| +3% | +$181K | ﹤0.01% | 3974 |
|
|
2021
Q2 | $5.84M | Buy |
390,719
+377,901
| +2,948% | +$5.93M | ﹤0.01% | 3826 |
|
|
2021
Q1 | $212K | Buy |
12,818
+12,810
| +160,125% | +$242K | ﹤0.01% | 4733 |
|
|
2020
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 5132 |
|
|
2020
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 5115 |
|
|
2020
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 5080 |
|
|
2020
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 5035 |
|
|
2019
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 5030 |
|
|
2019
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 5032 |
|
|
2019
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 5051 |
|
|
2019
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 4996 |
|
|
2018
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 5019 |
|
|
2018
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 5047 |
|
|
2018
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 5049 |
|
|
2018
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 4977 |
|
|
2017
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 4978 |
|
|
2017
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 5004 |
|
|
2017
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 5074 |
|
|
2017
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 5059 |
|
|
2016
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 3782 |
|
|
2016
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 3730 |
|
|
2016
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 3782 |
|
|
2016
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 3711 |
|
|
2015
Q4 | $0 | Buy |
+8
| New | +$98 | ﹤0.01% | 3489 |
|
Other funds holding MESO
AAP
PM
FFA
MGP
BlackRock's MESO Position: Q2 2026 in Review
BlackRock increased its Mesoblast (MESO) stake by 5.3% in Q2 2026, buying an estimated $497K and bringing the position to 664,280 shares worth $8.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3724.
BlackRock first reported a position in MESO in Q4 2015 and has held it in 43 quarters since. The position peaked at $14.4M in Q4 2024. 71 funds tracked by Wall St. Rank hold MESO as of Q2 2026.
- BlackRock held 664,280 shares of Mesoblast worth $8.99M as of Q2 2026.
- BlackRock bought 33,425 Mesoblast shares in Q2 2026, an estimated $497K.
- Mesoblast made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3724 holding.
- BlackRock first reported a position in Mesoblast in Q4 2015 and has held it in 43 quarters since.
- BlackRock's Mesoblast position peaked at $14.4M in Q4 2024.
- 71 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.